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 Abstract
BACKGROUND : Left ventricular end-diastolic volume (LVEDV) on echocardiography is one of the tests performed 
on heart failure. This refers to the volume of the left ventricle at the end of the diastolic phase, which would be 
increased when there is a disturbance in preload, afterload, and contractility factors. Matrix metalloproteinase-2 
(MMP2) is a marker of congestive heart failure that can be examined through laboratory examinations.
AIM: The objective of the study was to provide evidence of the association between MMP and inflammatory process 
as well as its correlation with LVEDV in children with heart failure.
METHODS : This was a cross-sectional study conducted on children aged 3 months–12 years old with heart failure, 
who visited Sanglah Hospital, Denpasar, Indonesia from May 2017 to March 2018. Echocardiographic examination 
(LVEDV) and blood samples were taken to measure the serum level of MMP2 on day 1 after the subjects were 
diagnosed with heart failure.
RESULTS: A total of 32 subjects with heart failure were analyzed in this study. Acyanotic congenital heart defect 
(CHD) was the most common cause of heart failure, as observed in 23 subjects (71.9%). Characteristics data 
revealed that 24 subjects (75%) were underweight, 23 (71.9%) had cardiomegaly, and 22 (68.8%) had mild heart 
failure. Data analysis showed a moderate positive correlation between MMP2 levels with LVEDV after controlling for 
the influence of age (p = 0.02; r = 0.425).
CONCLUSION: There was a moderate positive correlation between MMP2 level and LVEDV after controlling for the 
age factor.
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 Introduction
Heart failure is a public health problem that 
causes high morbidity and mortality in the world [1]. 
The incidence of heart failure due to cardiac structural 
abnormalities such as congenital heart disease is 
around 1–2 in 1000 live births, with the highest incidence 
occurring in the 1st year of life [2], [3], [4].
The diagnosis of heart failure in children 
is based on Ross criteria. These criteria have been 
modified to provide a general assessment in the severity 
of heart failure in children [3], [4], [5].
Left ventricular end-diastolic volume (LVEDV) 
on echocardiography is one of the tests performed on 
heart failure. This is the volume of the left ventricle at the 
end of the diastolic phase, which would be increased 
when there is a disturbance in the preload, afterload, 
and contractility factors. Laboratory tests for markers 
of heart failure are needed to support the diagnosis, 
including matrix metalloproteinase (MMP). The MMPs 
are a large family of Zn2+ enzymes responsible for tissue 
remodeling, vascular remodeling, and degradation of 
the extracellular matrix in various diseases [6].
Matrix metalloproteinase that is typically 
increased in patients with heart failure is MMP2. An 
increase in MMP2 above the mean serum level is 
associated with significantly high mortality and poor 
prognosis in patients with heart failure [7].
In patients with heart failure, the serum level 
of MMP2 was typically above the normal range in the 
decompensated state and is rapidly decreased throughout 
the process of compensation. The production of MMP is 
affected by several mechanisms, including changes in 
hemodynamic, neurohormonal, and inflammatory factors. 
Neurohormonal factors such as catecholamines and 
angiotensin II were increased in heart failure. Elevated 
plasma norepinephrine level activates the renin-angiotensin 
in the myocardium, and angiotensin II increases the level 
of MMP in heart failure [7]. The renin-angiotensin system 
increases the plasma level of angiotensin II. These 
hormonal changes will increase preload and afterload in 
the heart and play a role in cardiac remodeling which is 
considered to be the underlying cause of heart failure [8].
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The association between oxidative stress and 
MMP also influences the mechanism of heart failure. 
Reactive oxygen species (ROS) activates pro-MMP 
and contributes to the activation of regulatory factors 
such as nuclear factor κB (NF-κB) and activator 
protein-1 (AP-1). Mediators such as angiotensin II and 
endothelin I directly or indirectly affect the myocardium, 
which leads to heart failure [9].
MMP2 levels have increased significantly 
in patients with heart failure compared to normal 
adults [10]. The aim of this study is to prove that MMP2 
level is increased in children with heart failure.
Methods
This was an observational study with a cross-
sectional design to determine the correlation between 
serum level of MMP2 with left ventricular end-diastolic 
volume in children with heart failure.
This study was conducted from May 2017 to 
March 2018 in the Pediatric Ward of Sanglah Hospital, 
Denpasar, Indonesia. Examination of serum MMP2 
level was performed at Prodia Denpasar Laboratory.
Eligibility criteria
The subjects in this study were children aged 3 
months–12 years with heart failure, who fulfilled the 
inclusion and exclusion criteria. Inclusion criteria 
include children with heart failure due to acyanotic heart 
disease aged 3 months–12 years. Exclusion criteria 
include patients with comorbidities such as sepsis, 
renal failure, diabetic ketoacidosis, and cancer.
Procedure
Sampling was conducted through consecutive 
random sampling until the number of samples was 
reached.
Subjects with heart failure, who fulfilled the 
eligibility criteria were given complete information 
regarding this study and were asked for their 
willingness to participate in the study and signed the 
informed consent after receiving and understanding the 
information provided. Echocardiographic examination 
(LVEDV) was performed by 1 pediatric cardiology 
consultant, and blood samples were taken to measure 
the serum level of MMP 2. The measurement serum 
level of MMP2 using the Quantikine Immunoassay 
method. Laboratory measurements were conducted by 
Prodia laboratory staff on day I after the subjects were 
diagnosed with heart failure.
Heart failure was diagnosed based on the 
Ross criteria, and diagnoses were made by a pediatric 
cardiology consultant at Sanglah General Hospital, 
Denpasar, Indonesia. Based on the Ross score, we 
divided into four groups: Those with scores of 0–2 were 
without heart failure, those with scores of 3–6 were 
diagnosed as mild heart failure, those with scores of 
7–9 were diagnosed as moderate heart failure, and 
those with scores of 10–12 were diagnosed with severe 
heart failure [5].
MMP2 is an endopeptidase family that was 
typically increased in heart failure. The level of MMP2 
in the serum was examined using the Quantikine 
Immunoassay method, with a standard range of 
0.5–32 ng/ml. A serum MMP level of >32 ng/ml was 
considered increased. LVEDV is the volume of the left 
ventricle at the end of the diastolic phase, as measured 
through echocardiography performed by a pediatric 
cardiology consultant, using a modified Simpson 
technique. Results were expressed in ml/m2.
Statistics
Data were analyzed using a statistical program: 
The normality of the study was tested using the Shapiro-
Wilk test. Descriptive analysis was performed on the 
characteristics of the subjects. Correlation analysis was 
conducted for data with normal distribution using the 
Spearman correlation test, with a p < 0.05 considered 
statistically significant. 
Ethical aspect
This study was approved by the ethical 
committee of Sanglah Hospital, with protocol number 
1027/UN.14.2/KEP/2017.
Results
This study was conducted from May 2017 to 
March 2018 in the Pediatric Ward at Sanglah Hospital, 
Denpasar, Indonesia. During the study period, there 
were 32 children with heart failure who fulfilled the 
inclusion criteria.
Characteristics of subjects are shown in 
Table 1, including gender, age, type of heart disease, 
nutritional status, cardiomegaly, and heart failure score. 
The most common cause of heart failure in the study 
was acyanotic heart disease, which was observed in 23 
subjects (71.9%).
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Characteristics of heart failure score
The most common physical examination finding 
in heart failure as measured using Ross criteria was 
tachypnea (22 subjects). Heart failure characteristics 
based on Ross criteria are presented in Table 2.
Table 2: Characteristics of heart failure
Characteristics n = 32
Diaphoresis, n (%)
Head only, at exertion
Head and body at exertion
Head and body at rest
19 (59.4)
12 (37.5)
1 (3.1)
Tachypnea, n (%)
Rare
Several times
Frequent
10 (31.3)
18 (56.3)
4 (12.5)
Breathing, n (%)
Normal
Retractions
Dyspnea
1 (3.1)
30 (93.8)
1 (3.1)
Respiratory rate, n (%)
Normal
Fast
Very fast
0 (0)
22 (68.8)
10 (31.3)
Heart rate, n (%)
Normal
Fast
Very fast
2 (6.3)
21 (65.6)
9 (28.1)
Hepatomegaly, n (%)
< 2 cm
2–3 cm
>3 cm
17 (53.1)
11 (34.4)
4 (12.5)
Correlation between serum MMP2 level 
and LVEDV
Table 3 showed the normality test of MMP2 
level and LVEDV preceding the correlation analysis. 
The distribution of LVEDV data, as shown in the table, 
was non-normally distributed with a p = 0.003. Median 
LVEDV was 60.1 with IQR of 60.6. Data distribution for 
serum level of MMP 2 was normal with a mean of 324, 
and a p = 0.296.
Spearman correlation test was used due to the 
fact that not all of the data were normally distributed. 
Data analysis revealed there was no correlation 
between serum level of MMP2 and LVEDV in children 
with heart failure, with a p = 0.873. An analysis was 
performed to determine whether age affected LVEDV; 
thus, a partial correlation analysis was performed. The 
analysis revealed a correlation between serum level of 
MMP2 with LVEDV after controlling for the influence of 
age, with a p = 0.02. The result of this analysis is shown 
in Table 4.
Table 4: Partial correlation between MMP2 and LVEDV before 
and after controlling for age factor
Variable Adjustment LVEDV
r coefficient p value
MMP2 Non-adjusted −0.029 0.873
MMP2 Age-adjusted 0.406 0.02
Figure 1 presented a scatter plot diagram of the 
partial correlation analysis, which showed a moderate 
correlation between serum level of MMP2 and LVEDV 
after controlling for age with an r value = 0.425. The 
analysis revealed a significant correlation between 
serum level of MMP2 and LVEDV in subjects aged 
2 years and above.
 
Figure 1: Scatter plot diagram of a partial correlation between MMP2 
and LVEDV in children >2 years old
Discussion
A total of 32 subjects participated in this study. 
Most of the subjects were female (20 subjects), and 
a majority of the subjects belong to the >5 years age 
group. Sani et al. found that rheumatic heart disease 
was the most common heart disease in children 
>5 years of age (42.7%) [11]. In this study, we found 
that the most prevalent heart disease was congenital 
heart disease, which made up for 75% of all cases.
The most common cause of heart failure in 
children was congenital heart disease (CHD). Ventricular 
septal defect is the most common CHD observed in 
Table 1: Characteristics of subjects
Characteristics n = 32
Gender, n (%)
Male
Female
12 (37.5)
20 (62.5)
Age (years), median 
< 1 years
1–5 years
> 5 years 
13 (40.7)
5 (15.6)
14 (43.7)
Heart disease, n (%)
Acyanotic CHD
VSD
PDA
ASD
Cardiomyopathy
Dilated
Acquired heart disease (RHD)
24 (75)
13 (40.6)
10 (31.3)
1 (3.1)
1 (3.1)
1 (3.1)
7 (21.9)
Nutritional status, n (%)
Well-nourished
Underweight
Severe malnutrition
7 (21.9)
24 (75.0)
1 (3.1)
Cardiomegaly, n (%)
Yes
No
23 (71.9)
9 (28.1)
Ross criteria, n (%)
Mild
Moderate
Severe
22 (68.8)
9 (28.1)
1 (3.1)
Table 3: Normality test of LVEDV and serum MMP2 level
Variable Mean (SD) p
LVEDV (ml) 68.98 ± 45.27 0.003
Serum level of MMP 2 (ng/dl) 324 ± 103.1 0.296
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children. In this study, we found that the most common 
cause of heart failure was VSD. Similarly, Abdulkadir 
et al. also found that the most prevalent CHD in children 
was VSD (40.6%) [12].
Malnutrition is a very common problem in 
children with CHD [13]. High basal metabolic rate 
and inadequate nutrient intake are the main causes 
of malnutrition in children with CHD [14]. In this study, 
we found that most subjects (24 subjects, 75%) were 
underweight. Similarly, Isezuo et al. found that 72.9% of 
children with CHD were underweight [15].
Diagnoses of heart failure were made using 
modified Ross Criteria. In this study, we found that most 
subjects had mild heart failure (22 subjects, 68.8%). 
Based on characteristics data, the most common 
symptoms were retraction (93.8%), rapid respiratory 
rate (68.8%), tachycardia (65.6%), diaphoresis in the 
head during activities (59.4%), tachypnea (56.3%), and 
hepatomegaly of <2 cm (53.1%).
Left ventricular end-diastolic volume (LVEDV) 
is the volume of the left ventricle at the end of the 
diastolic phase, which would be increased when there 
is a disturbance in preload, afterload, and contractility 
factors. Increased LVEDV results in increased heart 
load, causing the body to perform a compensation 
mechanism. When the heart compensation mechanism 
failed, a decompensation mechanism occurs which 
results in ROS activation, which then activates MMP 
production. The production of MMP is affected by 
neurohormonal factors, such as catecholamines 
and angiotensin II, which were typically increased in 
heart failure. Elevated plasma norepinephrine level 
activates the renin-angiotensin in the myocardium, 
and angiotensin II increases the level of MMP in heart 
failure [7]. The renin-angiotensin system increases the 
plasma level of angiotensin II. These hormonal changes 
will increase preload and afterload in the heart and play 
a role in cardiac remodeling which is considered to be 
the underlying cause of heart failure [8].
The current study on the correlation between 
MMP2 and LVEDV in children with heart failure is the 
first conducted in children. A study by Cheng et al. in 
pediatric population showed a significant increase 
in serum level of MMP2 in CHD children with VSD 
compared to the control group, with a p < 0.01 [16]. 
Another study by Kihc et al. on pediatric population with 
CHD showed that there was no significant increase 
in serum level of MMP in the cyanotic CHD group 
compared to the control group [17]. A study by Yamazaki 
et al. in adult population showed that the serum level of 
MMP2 was significantly higher in patients with severe 
heart failure than in patients with mild heart failure, with 
a p < 0.01 [18]. Another study by Shirakabe et al. in the 
adult population with acquired heart disease showed 
that serum level of MMP2 was significantly higher in 
patients with heart failure on the 1st day. Serum level 
of MMP2 was significantly decreased on the third day 
compared to the 1st day with a p < 0.001 [7]. In this 
study, we found that there was no correlation between 
serum level of MMP2 and LVEDV in children with heart 
failure (p = 0.873). This finding may be due to some 
of the samples for MMP2 level examination was taken 
after the 1st day of the decompensation phase of heart 
failure. Serum level of MMP2 was found to be increased 
in the decompensation phase of heart failure [7].
Correlation between serum level of MMP2 
and LVEDV in children with heart failure after 
controlling for age
Matrix metalloproteinase is associated with 
diastolic dysfunction and heart failure [19]. Diastolic 
function is an important component of the left ventricular 
function that can cause symptoms of heart failure [20]. 
The mechanism underlying heart failure includes 
impaired cardiac contractility, which results in lower-
than-normal cardiac output [21]. The decreased cardiac 
output is due to decreased contractility, increased 
afterload, or increased preload, resulting in decreased 
ejection fraction and increased LVEDV. Age is one of 
the factors that affect LVEDV. This is due to the fact that 
with increasing age, structural, and functional changes 
in the heart also increases. Functional changes and 
compensation mechanisms that occur with increasing 
age include changes in heart rate, cardiac systolic 
function, cardiac diastolic function, and contractility. 
Normal diastolic filling can be divided into two phases, 
namely the passive (represented by the “E wave” on 
echocardiographic study of transmitral flow) and active 
(represented by an A wave and produced by atrial 
contraction) phases. Diastolic filling phase becomes 
slower with age, resulting in a difference in the proportion 
of diastolic filling in the passive phase. As the bulk of 
ventricular filling shifts to later in diastole and there is 
significant atrial enlargement with aging, the atrium 
contributes a greater portion of the total LVEDV [22]. 
In this study, we found that the younger 
the age of the child, the lower the value of LVEDV. A 
study by Cain et al. showed an increase in LVEDV in 
adolescence, and there were no significant differences 
between the sexes with a p = 0.65 [23]. In this study, 
we found a correlation between serum level of MMP2 
with LVEDV after controlling for age with a p = 0.02. We 
also obtained significant results in subjects over 2 years 
of age. The scatter plot graph (Figure 1) showed a 
moderate correlation between serum level of MMP2 and 
LVEDV after controlling for age factor with an r of 0.425.
Conclusion
This study showed a moderate positive 
correlation between MMP2 levels with LVEDV after 
controlling the influence of age.
 Mahakrishna et al. Correlation between Serum Level of MMP2 with LVEDV in Children with Heart Failure
Open Access Maced J Med Sci. 2020 Oct 29; 8(B):973-977. 977
Acknowledgment
The authors would like to thank Sanglah 
General Hospital Denpasar Bali, Indonesia and the 
parents of patients who have been willing to participate 
in this study.
References
1. Mueller GC, Schlueter EL, Arndt F, Khatami JW, Mir TS. 
Prevalence of anemia in children with congestive heart failure 
due to dilated cardiomyopathy. Int J Pediatr. 2012;2012:452909. 
https://doi.org/10.1155/2012/452909
 PMid:23213342
2. Beggs S, Thompson A, Nash R, Tompson A, Peterson G. 
Cardiac Failure in Children. 17th Expert Committee on the 
Selection and Use of Essential Medicines. Geneva: World 
Health Organization; 2009. p.1-31.
3. Hsu DT, Pearson GD. Heart failure in children: Part I: History, 
etiology, and pathophysiology. Circ Heart Fail. 2009;2:63-70. 
https://doi.org/10.1161/circheartfailure.108.820217
 PMid:19808316
4. Frobel AK, Hulpke WM, Schmidt KG, Laer S. Beta blockers for 
congestive heart failure in children. Cochrane Database Syst 
Rev. 2009;1:CD007037. https://doi.org/10.1002/14651858.
cd007037.pub2
 PMid:19160314
5. Ross RD. The ross classification for heart failure in children 
after 25 years: A review and an age stratified revision. Pediatr 
Cardiol. 2012;33(8):1295-300. https://doi.org/10.1007/
s00246-012-0306-8
 PMid:22476605
6. Verma RP, Hansch C. Matrix metalloproteinases (MMPs): 
Chemical-biological functions and (Q)SARs. Bioorg Med Chem. 
2007;15(6):2223-68. https://doi.org/10.1016/j.bmc.2007.01.011
 PMid:17275314
7. Shirakabe A, Asai K, Hata N, Yokoyama S, Shinada T, 
Kobayashi N, et al. Clinical significance of matrix 
metalloproteinase (MMP)-2 in patients with acute heart 
failure. Int Heart J. 2010;51(6):404-10. https://doi.org/10.1536/
ihj.51.404
 PMid:21173516
8. Muller AL, Dhalla AS. Role of various proteases in cardiac 
remodeling and progression of heart failure. Heart 
Fail Rev. 2012;17(3):395-409. https://doi.org/10.1007/
s10741-011-9269-8
 PMid:21739365
9. Tousoulis D, Kampoli AM, Papageorgiou N, Antoniades C, 
Siasos G, Latsios G, et al. Matrix metalloproteinases in heart 
failure. Curr Top Med Chem. 2012;12(10):1181-91. https://doi.
org/10.2174/1568026611208011181
 PMid:22519448
10. Banfi C, Cavalca V, Veglia F, Brioschi M, Barcella S, Mussoni L, 
et al. Neurohormonal activation is associated with increased 
levels of plasma matrix metalloproteinase 2 in human heart 
failure. Eur Heart J. 2005;26(5):481-8. https://doi.org/10.1093/
eurheartj/ehi073
 PMid:15618033
11. Sani UM, Ahmed H, Jiya NM. Pattern of acquired heart 
diseases among children seen in Sokoto, North-Western 
Nigeria. Niger J Clin Pract. 2015;18(6):718-25. https://doi.
org/10.4103/1119-3077.163284
 PMid:26289507
12. Abdulkadir M, Abdulkadir Z. A systematic review of trends 
and patterns of congenital heart disease in children in Nigeria 
from 1964-2015. Afr Health Sci. 2016;16(2):367-77. https://doi.
org/10.4314/ahs.v16i2.5
 PMid:27605952
13. Hassan BA, Albanna EA, Morsy SM, Siam AG, Shafie MM, 
Elsaadany HF, et al. Nutritional status in children with 
un-operated congenital heart disease: An Egyptian center 
experience. Front Pediatr. 2015;3:53. https://doi.org/10.3389/
fped.2015.00053
 PMid:26125014
14. Ratanachu S, Pongdara A. Nutritional status of pediatric patients 
with congenital heart disease: Pre and post cardiac surgery. J 
Med Assoc Thai. 2011;94(3):S133-7.
 PMid:22043766
15. Isezuo KO, Waziri UM, Sani UM, Garba BI, Ahmad MM, 
Adamu A, et al. Nutritional status of children with congenital 
heart diseases at a university teaching hospital, North-Western 
Nigeria. Int J Trop Dis Health. 2017;25(4):1-8. https://doi.
org/10.9734/ijtdh/2017/35964
16. Cheng KS, Liao YC, Chen MY, Kuan TC, Hong YH, Ko L. 
Circulating matrix metalloproteinase 2 and 9 enzyme activities 
in the children with ventricular septal defect. Int J Biol Sci. 
2013;9(6):557-63. https://doi.org/10.7150/ijbs.6398
 PMid:23847438
17. Kihc Z, Ucar B, Ozdemir G, Colak O, Bal C, Ertugrul T. 
Circulating matrix metalloproteinase and tissue inhibitors of 
metalloproteinases levels in pediatric patients with congenital 
heart disease: Relationship to cardiac functions. Anatol J Cardiol. 
2014;14(6):531-41. https://doi.org/10.5152/akd.2014.4950
 PMid:25233500
18. Yamazaki T, Lee JD, Shimizu H, Uzui H, Ueda T. Circulating 
matrix metalloproteinase 2 is elevated in patients with 
congestive heart failure. Eur J Heart Fail. 2004;6:41-5. https://
doi.org/10.1016/j.ejheart.2003.05.002
 PMid:15012917
19. Baggen VJ, Eindhoven JA, Bosch AE, Witsenburg M, 
Cuypers JA, Langstraat JS, et al. Matrix metalloproteinase as 
candidate biomarkers in adults with congenital heart disease. 
Biomarkers. 2016;21(5):466-73. https://doi.org/10.3109/13547
50x.2016.1153722
 PMid:26983903
20. Panesar DK, Burch M. Assessment of diastolic function in 
congenital heart disease. Front Cardiovasc Med. 2017;4:5. 
https://doi.org/10.3389/fcvm.2017.00005
 PMid:28261582
21. Figueroa MS, Peters JI. Congestive heart failure: Diagnosis, 
pathophysiology, therapy, and implications for respiratory care. 
Respir Care. 2006;51(4):403-12.
 PMid:16563194
22. Strait JB, Lakatta EG. Aging-associated cardiovascular 
changes and their relationship to heart failure. Heart Fail Clin. 
2012;8(1):143-64. https://doi.org/10.1016/j.hfc.2011.08.011
 PMid:22108734
23. Cain PA, Ahl R, Hedstrom E, Ugander M, Johnsson AA, 
Friberg P, et al. Age and gender specific normal values of 
left ventricular mass, volume and function for gradient echo 
magnetic resonance imaging: A cross sectional study. BMC Med 
Imaging. 2009;9:2. https://doi.org/10.1186/1471-2342-9-2
 PMid:19159437 
